Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances and Prospects in the Treatment of Pancreatic Cancer
Huaiyu Duan, li li, Shiming He
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 3973-3988
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Nano-Drug Delivery Systems Targeting CAFs: A Promising Treatment for Pancreatic Cancer
Mingjie Wang, Wenxiang Xue, Hanghang Yuan, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2823-2849
Open Access | Times Cited: 7
The role of monoclonal antibodies in the treatment of pancreatic and colon cancers
Soumya Dakshinamurthy
Elsevier eBooks (2025), pp. 389-412
Closed Access
Novel dual-targeting PROTAC degraders of GSK-3β and CDK5: A promising approach for pancreatic cancer treatment
Neerasa Jayaprakash, Byeonggwan Kim, Hye Jin Chung
Bioorganic & Medicinal Chemistry (2025) Vol. 120, pp. 118085-118085
Closed Access
Recent advances in sonodynamic therapy strategies for pancreatic cancer
Peng Cheng, Shuai Ming, Wei Cao, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 1
Closed Access | Times Cited: 4
Plasma metabolites as mediators in immune cell-pancreatic cancer risk: insights from Mendelian randomization
Ke Zhang, Jie Zhu, Peng Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Breaking the stromal barrier in pancreatic cancer: Advances and challenges
Mohana Chakkera, Jeremy B. Foote, Batoul Farran, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 1, pp. 189065-189065
Closed Access | Times Cited: 10
Corosolic acid enhances oxidative stress-induced apoptosis and senescence in pancreatic cancer cells by inhibiting the JAK2/STAT3 pathway
Xu Luo, Zhengchen Ye, Chenglei Xu, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 2
REEP3 is a potential diagnostic and prognostic biomarker correlated with immune infiltration in pancreatic cancer
Guohua Liu, Xiaoyu Tan, Zhen-Yue Xu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Theranostic nanoparticles for detection and treatment of pancreatic cancer
Happy Agarwal, Ryan C. Bynum, Nada Saleh, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 4
Closed Access | Times Cited: 2
Role of m6A modification in regulating the PI3K/AKT signaling pathway in cancer
Jie Liu, Xinyu Gu, Zhenjie Guan, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Oncolytic adenovirus as pancreatic cancer-targeted therapy: Where do we go from here?
A‐Rum Yoon, JinWoo Hong, Bo‐Kyeong Jung, et al.
Cancer Letters (2023) Vol. 579, pp. 216456-216456
Open Access | Times Cited: 6
In vitro Cytotoxicity Evaluation of Dandelion Root Ethanol Extract on PANC-1 Cell Line
Aliye Aras, Emine Arslan, Büşra Özçay
Mutiara Medika Jurnal Kedokteran dan Kesehatan (2024) Vol. 24, Iss. 1, pp. 66-70
Open Access | Times Cited: 1
NIR-activated multifunctional agents for the combined application in cancer imaging and therapy
Paweł Repetowski, Marta Warszyńska, J. Da̧browski
Advances in Colloid and Interface Science (2024) Vol. 336, pp. 103356-103356
Open Access | Times Cited: 1
The role of LncRNA-MANCR induced by HIF-1a drive the malignant progression of pancreatic cancer by targeting miRNA-494/SIRT1 signaling axis under hypoxic conditions
Yan Jin, Hao Hu, Yitong Tian, et al.
Research Square (Research Square) (2024)
Open Access
AHNAK2 Promotes the Progression of Pancreatic Ductal Adenocarcinoma by Maintaining the Stability of c-MET
Z Chen, Pengbiao Miao, Hongcao Lin, et al.
Cancer Management and Research (2024) Vol. Volume 16, pp. 431-444
Open Access
Synergistic effect of additional anlotinib and immunotherapy as second‐line or later‐line treatment in pancreatic cancer: A retrospective cohort study
Boyu Qin, Qi Xiong, Lingli Xin, et al.
Cancer Innovation (2024) Vol. 3, Iss. 4
Open Access
In vitro photothermal therapy of pancreatic cancer mediated by immunoglobulin G-functionalized silver nanoparticles
Andreea Nedelcu, Teodora Mocan, L. Sabau, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Unraveling the interplay: exploring signaling pathways in pancreatic cancer in the context of pancreatic embryogenesis
Sashikanta Swain, Ravi Kant Narayan, P Mishra
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Lidamycin induces mitophagy in pancreatic cancer cells by regulating the expression of Mfn2
Boya Wu, Bing Qi, L Duan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
LINC01094: A Key Long Non-Coding RNA in the Regulation of Cancer Progression and Therapeutic Targets
Qiang Yi, Gangfeng Zhu, Weijian Zhu, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37527-e37527
Open Access
LINC01857 promotes cell proliferation and migration while dampening cell apoptosis in pancreatic cancer by upregulating CDC42EP3 via miR-450b-5p
Jianxin Zhang, Shen Yanbin, Dandan Ma, et al.
Heliyon (2024) Vol. 10, Iss. 21, pp. e38427-e38427
Open Access
Radiopharmaceuticals for Pancreatic Cancer: A Review of Current Approaches and Future Directions
Sara Calistri, Giuseppe Ottaviano, Alberto Ubaldini
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1314-1314
Open Access
Synthesis of pyridyl pyrimidine hedgehog signaling pathway inhibitors and their antitumor activity in human pancreatic cancer
Hongjuan Li, Miao Wang, Shu Han, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116961-116961
Closed Access
Combating PDAC Drug Resistance: The Role of Ref-1 Inhibitors in Accelerating Progress in Pancreatic Cancer Research
Eyram Kpenu, Mark R. Kelley
Journal of Cellular Signaling (2024) Vol. 5, Iss. 4, pp. 208-216
Closed Access
Molecular mechanism of pancreatic ductal adenocarcinoma: The heterogeneity of cancer-associated fibroblasts and key signaling pathways
Zhongyuan Hu, Ding Ding, Yu Song, et al.
World Journal of Clinical Oncology (2024) Vol. 16, Iss. 2
Closed Access
Page 1 - Next Page

Scroll to top